The central drug regulator released two lists – one was a list of 48 drugs that failed the quality tests and another had ...

According to DelveInsight’s analysis, the growth of the KRAS Inhibitors market is expected to be mainly driven by increasing incidence, a rise in awareness and access to treatment, and robust pipeline ...

The Central Drugs Standard Control Organisation (CDSCO) has flagged over 50 drugs, including Paracetamol, as 'not of standard ...

One of the major dangers of taking substandard medications is the risk of prolonged health issues. PCM (paracetamol), for ...

In its latest drug alert, the apex drug regulatory body, the Central Drug Standard Control Organization (CDSCO), has flagged ...

The CDSCO’s August 2024 report categorized several medications under its “Not of Standard Quality (NSQ Alert)” list, which ...

ASX falls on Wednesday with banks dragging down market. Lithium stocks surge on CATL suspension reports; MinRes jumps 16.2pc.